Advanced search
Publication Cover
Expert Review of Medical Devices Volume 13, 2016 - Issue 5
Submit an article Journal homepage
2,108
Views
8
CrossRef citations to date
0
Altmetric
Editorial

Tissue engineered heart valves: moving towards clinical translation

Maximilian Y. EmmertInstitute for Regenerative Medicine (IREM), University of Zurich, Zurich, Switzerland;Heart Center Zurich, University Hospital Zurich, Zurich, Switzerland;Wyss Translational Center Zurich, Zurich, SwitzerlandCorrespondence[email protected]
&
Simon P. HoerstrupInstitute for Regenerative Medicine (IREM), University of Zurich, Zurich, Switzerland;Heart Center Zurich, University Hospital Zurich, Zurich, Switzerland;Wyss Translational Center Zurich, Zurich, Switzerland
Pages 417-419 | Received 21 Dec 2015, Accepted 24 Mar 2016, Published online: 07 Apr 2016

References

  • Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–1011.
  • Supino PG, Borer JS, Preibisz J, et al. The epidemiology of valvular heart disease: a growing public health problem. Heart Fail Clin. 2006;2:379–393.
  • Toggweiler S, Humphries KH, Lee M, et al. 5-year outcome after transcatheter aortic valve implantation. J Am Coll Cardiol. 2013;61:413–419.
  • Yacoub MH, Takkenberg JJ. Will heart valve tissue engineering change the world? Nat Clin Pract Cardiovasc Med. 2005;2:60–61.
  • Kraehenbuehl TP, Zammaretti P, Van Der Vlies AJ, et al. Three-dimensional extracellular matrix-directed cardioprogenitor differentiation: systematic modulation of a synthetic cell-responsive PEG-hydrogel. Biomaterials. 2008;29:2757–2766.
  • Harken DE. Heart valves: ten commandments and still counting. Ann Thorac Surg. 1989;48:S18–S19.
  • Langer R, Vacanti JP. Tissue engineering. Science. 1993;260:920–926.
  • Weber B, Emmert MY, Schoenauer R, et al. Tissue engineering on matrix: future of autologous tissue replacement. Semin Immunopathol. 2011;33:307–315.
  • Schmidt D, Dijkman PE, Driessen-Mol A, et al. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells. J Am Coll Cardiol. 2010;56:510–520.
  • Cebotari S, Tudorache I, Ciubotaru A, et al. Use of fresh decellularized allografts for pulmonary valve replacement may reduce the reoperation rate in children and young adults: early report. Circulation. 2011;124:S115–S123.
  • Dohmen PM, Lembcke A, Holinski S, et al. Mid-term clinical results using a tissue-engineered pulmonary valve to reconstruct the right ventricular outflow tract during the Ross procedure. Ann Thorac Surg. 2007;84:729–736.
  • Horke A. Decellularization of aortic valves: only time will tell. Eur J Cardiothorac Surg. 2016;49:707–708.
  • Weber B, Scherman J, Emmert MY, et al. Injectable living marrow stromal cell-based autologous tissue engineered heart valves: first experiences with a one-step intervention in primates. Eur Heart J. 2011;32:2830–2840.
  • Roh JD, Sawh-Martinez R, Brennan MP, et al. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci U S A. 2010;107:4669–4674.
  • Emmert MY, Weber B, Behr L, et al. Transapical aortic implantation of autologous marrow stromal cell-based tissue-engineered heart valves: first experiences in the systemic circulation. JACC Cardiovasc Interv. 2011;4:822–823.
  • Emmert MY, Weber B, Behr L, et al. Transcatheter aortic valve implantation using anatomically oriented, marrow stromal cell-based, stented, tissue-engineered heart valves: technical considerations and implications for translational cell-based heart valve concepts. Eur J Cardiothorac Surg. 2014;45:61–68.
  • Emmert MY, Weber B, Wolint P, et al. Stem cell-based transcatheter aortic valve implantation: first experiences in a pre-clinical model. JACC Cardiovasc Interv. 2012;5:874–883.
  • Dijkman PE, Driessen-Mol A, Frese L, et al. Decellularized homologous tissue-engineered heart valves as off-the-shelf alternatives to xeno- and homografts. Biomaterials. 2012;33:4545–4554.
  • Weber B, Dijkman PE, Scherman J, et al. Off-the-shelf human decellularized tissue-engineered heart valves in a non-human primate model. Biomaterials. 2013;34:7269–7280.
  • Driessen-Mol A, Emmert MY, Dijkman PE, et al. Transcatheter implantation of homologous “off-the-shelf” tissue-engineered heart valves with self-repair capacity: long-term functionality and rapid in vivo remodeling in sheep. J Am Coll Cardiol. 2014;63:1320–1329.
  • Syedain Z, Reimer J, Schmidt J, et al. 6-Month aortic valve implantation of an off-the-shelf tissue-engineered valve in sheep. Biomaterials. 2015;73:175–184.
  • Emmert MY, Weber B, Falk V, et al. Transcatheter tissue engineered heart valves. Expert Rev Med Devices. 2014;11:15–21.
  • Schoen FJ. Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering. Circulation. 2008;118:1864–1880.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.